CLClifford Lawrence

Clifford Lawrence

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Clifford Lawrence has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • M.G.C. Dahl

    Department of Dermatology, Royal Victoria Infirmary, Newcastle‐upon‐Tyne NE1 4LP, U.K.

    2 shared publications
  • A.A. Lonsdale Eccles

    Department of Dermatology, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, U.K. *Department of Dermatology, Medical School, University of Newcastle upon Tyne, Newcastle upon Tyne, U.K.

    1 shared publication
  • A.J. Dickinson

    1 shared publication
  • M. Haniffa

    Department of Dermatology, Royal Victoria Infirmary, Newcastle‐upon‐Tyne NE1 4LP, U.K.

    1 shared publication
  • R J Turner

    Department of Dermatology, Royal Victoria Infirmary, Newcastle-upon-Tyne NE1 4LP, U.K.

    1 shared publication

Latest Publications

  • Formalin-fixed tissue Mohs surgery (slow Mohs) for basal cell carcinoma: 5-year follow-up data

    by C.M. Lawrence, M. Haniffa, M.G.C. Dahl

    Mohs surgery using a formalin-fixed tissue technique (slow Mohs) was used to treat 1090 basal cell carcinomas (BCCs) occurring in 1000 patients without Gorlin syndrome in a prospective, open nonrandomized trial of therapy carried out in a university dermatology department. To record outcomes and 5-year cure rates in these patients. Five multirecurrent BCCs could not be cleared and Mohs surgery was abandoned. In the remaining 1085 BCCs, after debulking, clearance was achieved with a mean of 1.7 stages and 7.7 blocks. Logistic regression analysis showed that large tumour size and position on the nose were the only factors that significantly predicted the risk of tumour excision requiring more than two Mohs stages. Wounds were managed by the Mohs surgeon (n = 917), by an oculoplastic surgeon (n = 117) and by a plastic or other surgeon (n = 56). The mean interval between the first Mohs excision and Mohs clearance, regardless of the closure technique, was 4.2 days (range 0-44) and the mean interval between tumour clearance and defect closure was 1.9 days (range 0-49). Reconstruction of 117 periocular defects by the oculoplastic surgeon was done at a mean of 0.8 days (range 0-6) after Mohs clearance. Reconstruction by the plastic surgeon was done at a mean of 10 days (range 0-49) after Mohs clearance. Five-year follow up was possible in 750 BCCs. Within this group 21 tumour recurrences were identified, giving a 5-year cure rate of 97.2% for all patients, 97.8% for primary BCC and 95.3% for recurrent BCC. The mean tumour recurrence time was 2.5 years (range 0.6-4.99) following Mohs excision. There was a higher risk of recurrence for big (four of 78; 5%) and recurrent (nine of 193; 5%) BCCs compared with other indications for Mohs surgery. The essential difference between frozen sections and formalin-fixed sections is the greater use of an automated laboratory system to process the smaller size and greater number of blocks produced using the latter process. An effective Mohs service based on formalin-fixed sections requires a minimum of three half-day operating sessions together with a pathology laboratory able to provide results routinely within 24-48 h. A formalin-fixed tissue Mohs service is useful for certain skin tumours and requires less technician time than a frozen section service but this advantage may not outweigh the inconvenience to the patient.


  • Selective sweat gland removal with minimal skin excision in the treatment of axillary hyperhidrosis: a retrospective clinical and histological review of 15 patients

    by C.M. Lawrence, A.A. Lonsdale Eccles

    Limited axillary skin excision and selective sweat gland removal from adjacent skin (Shelley's procedure) is currently rarely used for hyperhidrosis. To determine whether this technique is a good way of permanently reducing axillary sweating. This was a prospective, open, nonrandomized trial of the therapy, conducted in a university dermatology department. A small skin ellipse, parallel to the skin crease lines, was excised from the centre of the area of maximal sweating. The wound edges were undermined to the extent of maximal sweating and the skin reflected. Large visible sweat glands attached to the undersurface of the adjacent skin could be readily identified and were snipped off using scissors. We treated 15 axillae in eight patients with axillary hyperhidrosis. Sweat reduction was assessed by the patients who estimated the percentage reduction in sweating postoperatively. The scar appearance was graded by the surgeon. Haematoxylin and eosin-stained transverse sections of eight axillary skin ellipses from five subjects were examined histologically to establish the size, position and depth of the sweat gland tissue. All of the patients responded to treatment: mean sweat reduction was 65% (range 40-90%). Mean follow up was 1.3 years (range 0.1-6) and sweat reduction was maintained over this period. Histological material was available from five patients: sweat glands lay slightly deeper than hair follicles; glandular tissue occupied an average thickness of 3.5 mm in the 5-mm thick piece of skin. Apocrine gland lobules were more numerous and larger than eccrine gland lobules. Both gland types were in close apposition and did not occupy distinctly different depths within the skin. Local surgery using limited axillary skin excision and selective sweat gland removal remains one of the safest ways of permanently reducing axillary sweating.


  • Open Access

    Skin Excision and Osteophyte Removal Is Not Required in the Surgical Treatment of Digital Myxoid Cysts

    by Clifford Lawrence

    The cause of digital myxoid cysts (DMCs) is controversial. Earlier researchers1 believed that the cysts are degenerative in origin and unrelated to the adjacent joint. Most authorities believe that DMCs arise as a result of joint fluid leaking from the distal interphalangeal joint (DIPJ).2-4 The connection between the cyst and the DIPJ can be demonstrated by the appearance of dye in the cyst after injection of dye into the DIPJ.2 The site of leakage can be identified by raising a flap of skin to expose the subcutaneous tissues between the cyst and the DIPJ. In an earlier study,5 it was shown that identification of the DIPJ leakage site using methylene blue (MB) injection into the DIPJ and division of the connection between the cyst and the joint resulted in cure of the digital cyst in 94% of finger and 57% of toe cysts. The principle objectives of successful surgery are debated. Some researchers4 believe that cyst removal is required. Others6 believe that osteophytes on the adjacent DIPJ have to be removed to ensure therapeutic success. One study5 has proposed that any procedure that results in the DIPJ leakage point being sealed over by fibrosis following a surgical or destructive procedure is likely to be successful.


  • Open Access

    General practitioners with a special interest in dermatology – the dermatologist’s perspective

    by Clifford Lawrence

    The NHS plan promises the creation of general practitioners with a specialist interest (GPSIs) who will be able to provide an alternative referral resource for primary care. At present, only the specialties of orthopaedics, ophthalmology, ENT and dermatology, which have the longest waiting times for outpatient appointments, have been earmarked for GPSIs. The British Association of Dermatologists has examined, investigated and piloted several such schemes for dermatology provision. This paper summarises its principal conclusions.


  • Treatment options for giant congenital naevi

    by C M Lawrence

    Giant congenital naevi (GCN) are disfiguring, potentially malignant pigmented naevi present at birth. The naevus cells in GCN are found throughout the dermis and sometimes penetrate the subcutaneous septa. It is claimed that superficial, more heavily pigmented and biologically different naevus cells reside in the upper dermis. Partial removal of these superficial naevus cells by dermabrasion, laser therapy, curettage or shave excision is less traumatic than excision surgery and produces an acceptable cosmetic result. However, none of these techniques or excision of GCN to superficial fat completely removes the risk of malignant transformation.